- PLATFORM LOGINS
- |
- CONTACT
- Request a Demo
-
3000 RDU Center Drive, Suite 200, Morrisville, NC 27560
NantHealth is incorporated in the State of Delaware.
Information about NantHealth's management team is available on the Leadership section of this website.
Information about NantHealth's Board of Directors is available on the Board of Directors section of this website.
December 31st.
NantHealth’s common stock is traded under the ticker symbol NHIQ on OTC Markets. The first day of trading for NH’s common stock was on June 2, 2016.
Shares can be purchased through a stockbroker of your choice. NantHealth does not have a direct stock purchase program.
The CUSIP number is 630104107.
Ernst & Young LLP.
NantHealth’s transfer agent is American Stock Transfer & Trust Company, LLC
Contact information is:
Tiffany N. Thompson
Senior Relationship Manager
American Stock Transfer & Trust Company, LLC
One Embarcadero Center - Suite 566
San Francisco, CA 94111
Bus: 415.366.8087
eFax: 718.765.8795
Cell: 415.930.3597
tthompson@amstock.com
NantHealth’s transfer agent is American Stock Transfer & Trust Company, LLC
Contact information is:
Tiffany N. Thompson
Senior Relationship Manager
American Stock Transfer & Trust Company, LLC
One Embarcadero Center - Suite 566
San Francisco, CA 94111
Bus: 415.366.8087
eFax: 718.765.8795
Cell: 415415.930.3597
tthompson@amstock.com
NantHealth anticipates that it will retain all available funds and any future earnings, if any, for use in the operation of the company’s business and does not anticipate paying cash dividends in the foreseeable future.
Copies of NantHealth's news releases are available in the Press Releases section of this website.
Copies of NantHealth's filings with the SEC can be accessed through the SEC Filings section of this website or directly from the SEC at www.sec.gov.
You can sign up to receive NantHealth press releases and other company information via E-mail Alerts.
Please complete the Information Request form.